1. In Vivo
  2. >>Leadership

Illumina CSO Bentley Paints A Vision For The Future Of Precision Medicine

Sequencing A Whole Human Genome Is A Specialist Endeavor

 
• By Ashley Yeo

Genomic medicine is coming of age. For Illumina chief scientific officer David Bentley, that not only means improved technology, accuracy and coverage of gene sequencing and a broadening into cancer, but also a better understanding among the wider population of disease and precisely the benefits that gene sequencing can bring to patients – actual and pre-symptomatic.

DNA strand
"Genomics might have the capacity to predict what people are suffering from" • Source: Shutterstock

Diseases could be detected even before people experience symptoms, thanks to a pioneering new health data program as part of the UK’s modern Industrial Strategy. That was the message from the national government on July 23, as it announced a package of investment in Accelerating Detection of Disease, a new project to support research, prevention, early diagnosis and treatment for illnesses including cancer, dementia and heart disease in the UK.

The program promises to change the delivery of health care and medicine, building it around precision health care by making genomics central to early identification of disease. There is a longer-term aim to sequence 5 million genomes by 2023–2024, via a genomic volunteers program. This will improve the ability of health care professionals to tackle illnesses before symptoms occur

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from C-Suite Speaks

More from Leadership